“Development of Stimuli-Responsive Nanoparticles for Targeted Delivery of Encorafenib in BRAF-Mutant Cancer Therapy” (2026) International Journal of Research Development and Technology, 4(1), pp. 85–109. doi:10.62218/ijrdt.v4i1.170.